<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-pharmaceuticals-13-00096">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Costantini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bellet</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Pariano</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Renga</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Stincardini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Goldstein</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Garaci</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Romani</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>A reappraisal of thymosin Alpha1 in cancer therapy</article-title>
  <source>Front. Oncol.</source>
  <year>2019</year>
  <volume>9</volume>
  <fpage>873</fpage>
  <pub-id pub-id-type="doi">10.3389/fonc.2019.00873</pub-id>
  <?supplied-pmid 31555601?>
  <pub-id pub-id-type="pmid">31555601</pub-id>
 </element-citation>
</ref>
